Alison Liddy
CEO/Co-Founder
Relevium Medical
Relevium Medical develops pharmacological hydrogel treatments that combine natural biopolymers with active agents to provide targeted, long-lasting pain relief for patients suffering from osteoarthritis and other chronic pain conditions. Their approach addresses the urgent clinical need for effective pain management solutions, improving patient outcomes through tailored therapies.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$5.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Osteoarthritis and other chronic pain conditions present a significant challenge for patients, often requiring long-term pain management. Existing treatments may not provide sufficient or targeted relief, leading to reduced quality of life. There is a need for more effective and tailored pain management solutions.
Solution
Relevium Medical is developing pharmacological hydrogel treatments designed to provide targeted and long-lasting pain relief for individuals suffering from chronic pain. Their approach combines natural biopolymers with active pharmaceutical ingredients, enabling the creation of tailored therapies for different chronic pain conditions. These novel hydrogel products aim to offer superior efficacy compared to existing treatments, addressing the urgent clinical need for improved pain management and better patient outcomes. The company's science focuses on integrating natural biopolymers with pharmacologically active agents to create a range of novel platform hydrogel products.
Target Audience
The primary target audience includes patients suffering from osteoarthritis and other chronic pain conditions, as well as healthcare professionals seeking more effective pain management solutions.
Features
- Pharmacological hydrogel treatments combining natural biopolymers with active agents.
- Targeted drug delivery for localized pain relief.
- Tailored therapies designed for different chronic pain conditions.
- Novel platform hydrogel products with superior efficacy compared to existing treatments.